Monday, June 24, 2019
Surterra Wellness (Surterra), one of the fastest growing health and wellness companies in the United States (U.S.), today announced the close of its acquisition of Massachusetts-based New England Treatment Access (NETA), a premiere, vertically integrated cannabis company. The strategic acquisition fortifies Surterra's operations excellence, executive leadership team, and regional brand strength. The deal underscores Surterra as a national leader in the cannabis industry.
The Commonwealth of Massachusetts is one of the fastest growing medical and adult cannabis markets in the U.S. This is Surterra's second acquisition in six months, and reflects Surterra's approach of bringing operational cannabis companies with established brands, comparable values, and industry-leading standards under the Surterra umbrella. The deal adds a fourth U.S. cannabis market and another revenue-generating vertical operation to Surterra's rapidly expanding national footprint, which also includes operations Florida, Nevada and Texas. The combined company will have more than 1,500 employees.
"This is a synergistic partnership. NETA's foundational values and reputable track record align with Surterra's own vision for long-term success in this rapidly evolving cannabis industry. We welcome the talented NETA leadership team and their proven operations and product development expertise. Their experience will accelerate Surterra's ability to quickly and strategically scale as we become a global frontrunner in this space," said Surterra Chief Executive Officer William "Beau" Wrigley, Jr. "Surterra will immediately integrate NETA's best practices in patient and customer service, research and development, product production, compliance, and year-round indoor grow capabilities across our company's operations. We thank the Cannabis Control Commission for its approval of the acquisition and the communities of Brookline, Franklin, and Northampton for all of their support."
NETA Co-founder Kevin Fisher joins Surterra's leadership team as Executive Director of Operations, effective immediately. An industry pioneer in regulated medical and adult-use cannabis, Fisher has owned and operated facilities in Colorado and Massachusetts under the Rocky Mountain Remedies and NETA brands since 2009. Fisher also co-founded and served as the CEO of Molecular Infusions (Mi), a world class, cannabinoid-focused, biopharmaceutical company based in Boston.
"NETA's leadership and talented employees are thrilled to join Surterra. Together, we can build upon what NETA has already accomplished in ways that bring superior products and services to our current, and future, patients and customers. Like us, Surterra seeks meaningful collaborations with best-in-class, like-minded partners. They understand the long-term value of building brands and operational capabilities needed to execute on a large scale," said Kevin Fisher. "NETA will continue to provide patients and customers in the Commonwealth of Massachusetts with the high-quality brands and extraordinary service that they have come to expect. Additionally, our focus on the deployment of strong diversity programs and strategic community partnerships will go forward unabated."
